FDA Investigator Chaltu Nwakijra
Chaltu Nwakijra has conducted inspections on 23 sites in 1 countries as of 20 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
20 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Chaltu Nwakijra:
Adriana N Jimenez Lopez,
Alice S Tsao,
Alison N Stieg,
Amanda B Athey,
Amber G Chung,
Amy Devlin, PhD,
Amy N Chen,
Anastasia G Lolas,
Anastasia I Onuorah,
Andrea Siegel, PhD,
Andrew J Howard,
Anjali Shukla, PhD,
Ashley L Reiber,
Atul J Agrawal,
Austin B Appler,
Barbara A Gullick,
Barbara J Holladay,
Barbara Janine Breithaupt,
Bijoy Panicker,
Bo Chi, PhD,
Brian M Janelsins, PhD,
Brooke K Higgins,
Brooke K Seeman,
Bruce E Kummer,
Byungja E Marciante,
Candice C Mandera,
Candice J Cortes,
CDR Ileana Barreto Pettit,
Charles R Bonapace, PhD,
Chiang Syin, PhD,
Christian D Lynch (CDL),
Christina K Theodorou,
Christine M Whitby, CSO,
Christopher R Richardson,
Clarice J Ahn,
Collins M Mason,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Daniel R Azar,
David A Oluwo,
Debra Bower,
Dennis L Doupnik,
Deyaa Shaheen,
Diane T Bargo,
Diane T O'brien,
Donald C Obenhuber, PhD,
Douglas A Campbell,
Dr. Dominick Roselle,
Dr. Mark J Seaton, PhD,
Dr. Roslyn F Powers,
Dr. Sriram Subramaniam, PhD,
Dr. Yubing Tang,
Dr. Zhihao Qiu (Peter), PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edette J Newby,
Edmund F Mrak, Jr,
Edward P Potter,
Elvis D Morton,
Emest F Bizjak,
Eric L Dong, BS,
Erin L Mcfiren,
Esaw,
Frances Namuswe, PhD,
George Pyramides,
Gifford Whitehurst, Jr,
Guerlain Ulysse,
Heath R Harley,
Hector Jcolon Torres,
Jacqueline Mdiaz Albertini,
Jaison J Eapen,
James M Mason,
James M Simpson,
James W Leonette,
Jamie D Richardson,
Jamie D Swann,
Janet A Rajan,
Jee Chung, PhD,
Jennifer Swisher, PhD,
Jessica K Yoon,
John Dan,
John P Mistler,
Johnna L Bleem,
Johnson,
Jonah S Ufferfilge,
Jonathan W Chapman,
Joseph W Matthews,
Julie A Silberberg,
Julie D Bringger,
Junho Pak,
Jyoti B Patel, PhD,
Kalavati Suvarna, PhD,
Katelyn Astaub Zamperini,
Kathleen M Jordan,
Kathy Lee,
Kenneth M Gordon,
Kenneth Nieves,
Ko U Min,
Kristina L Conroy,
Kshitij A Patkar,
Kurt A Brorson, PhD,
La Tasham Gunter,
Lakisha M Williams,
Lauren N Barber,
Lawrence Harmon, Jr,
Lawrence J Stringer,
LCDR Anastasia M Piliafas Brown,
LCDR Cornelius Brown, III,
Lori S Lawless,
LT Luis O Rodriguez,
LT Richard A Lyght,
Lynette P Salisbury,
Madushini Dharmasena, PhD,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Maria Gutierrez Lugo, PhD,
Mary E Farbman, PhD,
Massoud Motamed,
Matthew M Henciak,
Melissa J Garcia,
Melissa T Roy,
Merideth K Rose,
Michael F Skelly, PhD,
Michael Shanks, MS,
Michelle E Noonan Smith,
Michelle Marsh,
Mildred L Mccray,
Nancy M Espinal,
Nebil A Oumer,
Nicholas A Violand,
Nina D Patel,
Norman K Starks,
Olaide Akinmade,
Osama M Hamoud,
Patrick C Klotzbuecher,
Paula J Bretz,
Philip J Snoy,
Philip W Beck,
Pratik S Upadhyay, DDC,
Qin Xu,
Rabin N Ghoshal,
Rachael O Oyewole,
Rachel C Harrington,
Rebecca E Dombrowski,
Regina Gibson Melton,
Renisha M Shaw,
Richard Heath Coats,
Richard Ledwidge (nmi), PhD,
Rina Bhikha,
Robert J Martin,
Robert L Hummel,
Rose Ashley,
Sarah J Park,
Scott R Nichols, PhD,
Sean R Marcsisin,
Sena G Dissmeyer,
Shadia Zaman, PhD,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Simone E Pitts,
Sneha S Patel,
Spiridoula Dimopoulos,
Stephanie L Shapley,
Steven E Bowen, PhD,
Steven J Thurber,
Steven P Donald,
Susan J Essenmacher,
Susan M Jackson,
Tajah L Blackburn,
Tamal K Chakraborti, PhD,
Tamara N Champion,
Tamika White,
Tamil Arasu, PhD,
Tania E Vizcaino,
Teegan Dellibovi Ragheb, PhD,
Theresa M Smedley,
Thomas J Arista,
Thomas N Adjabeng,
Thuy T Nguyen, LCDR,
Timothy M Albright,
Tonia F Bernard,
Toyin B Oladimeji,
Valeria A Moore,
Viviana Matta,
Vivin George,
Walter L Fava,
Wanda Y Honeyblue,
Wayne L Jefferson,
Wendy G Tan, PhD,
William A Warnick,
William D Bassett, Jr,
William L Bargo,
Xiaoshi N Wang,
Yvins Dezan,
Zhongren Wu
Chaltu Nwakijra's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more